Cite
Dunne PD, Coleman HG, Bankhead P, et al. . Oncotarget. 2018;9(17):13834-13847doi: 10.18632/oncotarget.24481.
Dunne, P. D., Coleman, H. G., Bankhead, P., Alderdice, M., Gray, R. T., McQuaid, S., Bingham, V., Loughrey, M. B., James, J. A., McCorry, A. M. B., Gilmore, A., Holohan, C., Klingbiel, D., Tejpar, S., Johnston, P. G., McArt, D. G., Di Nicolantonio, F., Longley, D. B., & Lawler, M. (2018). . Oncotarget, 9(17), 13834-13847. https://doi.org/10.18632/oncotarget.24481
Dunne, Philip D, et al. "." Oncotarget vol. 9,17 (2018): 13834-13847. doi: https://doi.org/10.18632/oncotarget.24481
Dunne PD, Coleman HG, Bankhead P, Alderdice M, Gray RT, McQuaid S, Bingham V, Loughrey MB, James JA, McCorry AMB, Gilmore A, Holohan C, Klingbiel D, Tejpar S, Johnston PG, McArt DG, Di Nicolantonio F, Longley DB, Lawler M. . Oncotarget. 2018 Feb 13;9(17):13834-13847. doi: 10.18632/oncotarget.24481. eCollection 2018 Mar 02. PMID: 29568398; PMCID: PMC5862619.
Copy
Download .nbib